Search Results 81-90 of 1018 for ���������������������������������������������:PC90���

  1. A Study to Evaluate Safety of Enapotamab Vedotin in Patients with Solid Tumors - Mayo Clinic

    About this study. The purpose of the trial is to establish the tolerability of HuMax-AXL-ADC in a mixed population of patients with specified solid tumors.

  2. A Study of the Safety, Tolerability, and Drug/Body Interactions of C2N-8E12 in People with Progressive Supranuclear Palsy - Mayo Clinic

    The purpose of this study is to evaluate the safety, tolerability and drug/body interactions of C2N-8E12 in patients with progressive supranuclear palsy.

  3. hyperbaric oxygen therapy Archives - Mayo Clinic News Network

  4. PK and Safety of Paclitaxel Injection Concentrate for Nano-dispersion Alone and in Carboplatin Combination - Mayo Clinic

    This is a phase I study of PICN alone and in combination with carboplatin and consisting of 2 sequential parts. Part A will characterize the pharmacokinetic ...

  5. A Study to Test the Validity and Reliability of the PC 7 - Mayo Clinic

    A secondary, exploratory aim is to use the PC 7 to describe trajectories of spiritual concern among patients receiving PC. Participation eligibility.

  6. Hematology - Clinical trials

    Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.

  7. CT Scan Archives - Mayo Clinic News Network

  8. A Study to Determine the Efficacy and Safety of BIIB122 in Participants with Parkinson’s Disease - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. Supporting Patients Undergoing HIgh-Risk PCI Using a High-Flow PErcutaneous Left Ventricular Support Device - Mayo Clinic

    The HeartMate PHP System is a temporary (<6 hours) ventricular assist device indicated for use during high risk percutaneous coronary interventions (PCI) ...

  10. Study of SC-003 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer - Mayo Clinic

    SC-003 is an antibody-drug conjugate (ADC) comprised of a monoclonal antibody linked to a potent chemotherapy. Participation eligibility. Participant ...